70 related articles for article (PubMed ID: 1293934)
1. [Effects of platelet activating factor on the cerebrovascular permeability in rats and the protection by drug].
Sun DX; Huang TG; Zeng GQ; Zhu J; Ju DW; Rui YC
Yao Xue Xue Bao; 1992; 27(9):651-5. PubMed ID: 1293934
[TBL] [Abstract][Full Text] [Related]
2. Effects of a new platelet-activating factor antagonist, UR-12670, on several endotoxic shock markers in rats.
Balsa D; Merlos M; Giral M; Ferrando R; Garcia-Rafanell J; Forn J
Drugs Exp Clin Res; 1997; 23(5-6):191-9. PubMed ID: 9515229
[TBL] [Abstract][Full Text] [Related]
3. Inhibitor effect of apafant on bronchopulmonary responses to platelet activating factor and to antigen in rats.
Akagi M; Nishioka E; Kanoh R; Tachibana M; Fukuishi N
Arzneimittelforschung; 1997 Dec; 47(12):1364-9. PubMed ID: 9450165
[TBL] [Abstract][Full Text] [Related]
4. Platelet-activating factor stimulates arachidonic acid release and enhances thromboxane B2 production in intact fetal rat brain ex vivo.
Kunievsky B; Yavin E
J Pharmacol Exp Ther; 1992 Nov; 263(2):562-8. PubMed ID: 1432689
[TBL] [Abstract][Full Text] [Related]
5. Dauricine and anisodamine inhibited leukotrienes- and platelet activating factor-induced DNA synthesis and proliferation of bovine cerebral microvascular smooth muscle cells in culture.
Zeng GQ; Ju DW; Sun DX; Rui YC
Zhongguo Yao Li Xue Bao; 1993 Jul; 14(4):329-31. PubMed ID: 8249627
[TBL] [Abstract][Full Text] [Related]
6. Pharmacologic activity of bepafant (WEB 2170), a new and selective hetrazepinoic antagonist of platelet activating factor.
Heuer HO; Casals-Stenzel J; Muacevic G; Weber KH
J Pharmacol Exp Ther; 1990 Dec; 255(3):962-8. PubMed ID: 2262914
[TBL] [Abstract][Full Text] [Related]
7. Platelet-activating factor (PAF) mediation of rat anaphylactic responses to soluble immune complexes. Studies with PAF receptor antagonist L-652,731.
Doebber TW; Wu MS; Biftu T
J Immunol; 1986 Jun; 136(12):4659-68. PubMed ID: 3011900
[TBL] [Abstract][Full Text] [Related]
8. Platelet activating factor production in bovine cerebral microvascular endothelial cells and its drug inhibition.
Sun DX; Huang TG; Zeng GQ; Rui YC
Zhongguo Yao Li Xue Bao; 1993 Jan; 14(1):26-30. PubMed ID: 8503282
[TBL] [Abstract][Full Text] [Related]
9. Characterization of cutaneous vascular permeability induced by platelet-activating factor in guinea pigs and rats and its inhibition by a platelet-activating factor receptor antagonist.
Hwang SB; Li CL; Lam MH; Shen TY
Lab Invest; 1985 Jun; 52(6):617-30. PubMed ID: 3925239
[TBL] [Abstract][Full Text] [Related]
10. Comparative hemodynamics and cardiovascular effects of endotoxin and platelet-activating factor in rat.
Salari H; Demos M; Wong A
Circ Shock; 1990 Nov; 32(3):189-207. PubMed ID: 2261677
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological actions of PCA 4248, a new platelet-activating factor receptor antagonist: in vivo studies.
Fernández-Gallardo S; Ortega MP; Priego JG; de Casa-Juana MF; Sunkel C; Sánchez Crespo M
J Pharmacol Exp Ther; 1990 Oct; 255(1):34-9. PubMed ID: 2170626
[TBL] [Abstract][Full Text] [Related]
12. Modulation of microvascular hydraulic permeability by platelet-activating factor.
Victorino GP; Newton CR; Curran B
J Trauma; 2004 Feb; 56(2):379-84. PubMed ID: 14960983
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological activities of a novel thienodiazepine derivative as a platelet-activating factor antagonist. Effects on microvascular permeability, hypotension and nephrosis.
Sakuma Y; Shirato M; Nagaoka J; Obaishi H; Tsunoda H; Katayama S; Ono H; Katayama K
Arzneimittelforschung; 1991 Dec; 41(12):1255-9. PubMed ID: 1815526
[TBL] [Abstract][Full Text] [Related]
14. Mechanism of arachidonic acid liberation in platelet-activating factor-stimulated human polymorphonuclear neutrophils.
Nakashima S; Suganuma A; Sato M; Tohmatsu T; Nozawa Y
J Immunol; 1989 Aug; 143(4):1295-302. PubMed ID: 2545786
[TBL] [Abstract][Full Text] [Related]
15. Platelet-activating factor stimulates arachidonic acid metabolism in rat liver cells (C-9 cell line) by a receptor-mediated mechanism.
Levine L
Mol Pharmacol; 1988 Dec; 34(6):793-9. PubMed ID: 2849046
[TBL] [Abstract][Full Text] [Related]
16. Inhibitory effect of the Korean herbal medicine, Dae-Jo-Whan, on platelet-activating factor-induced platelet aggregation.
Chang GT; Kang SK; Kim JH; Chung KH; Chang YC; Kim CH
J Ethnopharmacol; 2005 Dec; 102(3):430-9. PubMed ID: 16125889
[TBL] [Abstract][Full Text] [Related]
17. Interaction of platelet-activating factor with endothelial and vascular smooth muscle cells in coculture.
Stoll LL; Spector AA
J Cell Physiol; 1989 May; 139(2):253-61. PubMed ID: 2715186
[TBL] [Abstract][Full Text] [Related]
18. The isolation and characterization of kadsurenone from haifenteng (Piper futokadsura) as an orally active specific receptor antagonist of platelet-activating factor.
Shen TY; Hwang SB; Chang MN; Doebber TW; Lam MH; Wu MS; Wang X
Int J Tissue React; 1985; 7(5):339-43. PubMed ID: 2997065
[TBL] [Abstract][Full Text] [Related]
19. The effect of platelet-activating factor (PAF), histamine, and ethanol on vascular permeability of the guinea pig conjunctiva.
Stock EL; Roth SI; Kim ED; Walsh MK; Thamman R
Invest Ophthalmol Vis Sci; 1990 May; 31(5):987-92. PubMed ID: 2335460
[TBL] [Abstract][Full Text] [Related]
20. Tumor necrosis factor primes the effects of platelet-activating factor on rat vascular permeability.
Sirois MG; Plante GE; Braquet P; Sirois P
J Lipid Mediat; 1990; 2 Suppl():S109-17. PubMed ID: 2133277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
